Concentrix (CNXC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
20 Jan, 2026Executive summary
Q3 revenue reached $2.4 billion, up 46.2% year-over-year, driven by the Webhelp acquisition and strong bookings, especially in AI-driven solutions and client consolidations.
Net income for the quarter was $16.6 million, down 78.6% year-over-year, mainly due to higher amortization and integration costs from the Webhelp combination.
Strategic focus on higher-value, technology-enabled contracts, reducing exposure to price-led commodity business, now less than 7% of revenue.
Launched iX Hello, the first product in the Intelligent Experience suite, targeting GenAI productivity across client operations.
Returned $60 million to shareholders via dividends and share repurchases; increased quarterly dividend by 10%.
Financial highlights
Non-GAAP operating income was $331 million, up $100 million year-over-year; non-GAAP operating margin at 13.9%, down 20 bps YoY but up 40 bps sequentially.
Adjusted EBITDA reached $388 million, up $119 million YoY; adjusted EBITDA margin at 16.3%.
Non-GAAP net income was $192 million, up $49 million YoY; non-GAAP EPS at $2.87, up $0.11 YoY.
GAAP net income was $17 million, impacted by $117 million in amortization, $36 million in integration costs, and $33 million in FX losses.
Adjusted free cash flow was $135 million, below expectations due to client collection delays and higher integration spending.
Outlook and guidance
Q4 revenue expected at $2.42–$2.47 billion, pro forma constant currency change of -0.5% to +1.5%.
Q4 non-GAAP operating income guidance: $335–$355 million; non-GAAP EPS: $2.90–$3.16.
Full-year 2024 revenue expected at $9.591–$9.641 billion, 2.2–2.7% pro forma constant currency growth.
Full-year non-GAAP operating income: $1.306–$1.326 billion; non-GAAP EPS: $11.05–$11.31.
Adjusted free cash flow for 2024 expected at $625–$650 million; net leverage targeted at 2.8x adjusted EBITDA by year-end.
Latest events from Concentrix
- Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing27 Feb 2026 - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing13 Feb 2026 - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing13 Feb 2026 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 20243 Feb 2026 - Q1 growth strong, Webhelp integration on track, and generative AI seen as a major opportunity.CNXC
BofA Securities 2024 Global Technology Conference1 Feb 2026 - Record revenue and cash flow in 2025 set the stage for further growth in 2026.CNXC
Q4 202513 Jan 2026 - FY24 revenue hit $9.62B with strong cash flow; FY25 set for margin and cash flow growth.CNXC
Q4 202410 Jan 2026 - Q1 profit and margins rose on strong AI demand; full-year guidance and returns reaffirmed.CNXC
Q1 202526 Dec 2025 - Gen AI adoption and new services drive growth, margin expansion, and deeper client relationships.CNXC
Investor Update20 Dec 2025